Largely Unchanged Annual Incidence and Overall Survival of Pleural Mesothelioma in the USA
Projections based on regulations curtailing asbestos use in the USA suggest that peak incidence of pleural mesothelioma would occur between 2000 and 2005 and then decline. We analyzed the National Cancer Database (NCDB) to assess current trends in disease incidence, patient demographics, cancer treatment, and survival.
The NCDB was queried to identify patients diagnosed with pleural mesothelioma from 2004 through 2014. Clinical and pathologic characteristics, treatments, and survival were analyzed. Risk factors for death were identified by multivariable Cox regression.
A total of 20,988 patients with pleural mesothelioma were reported to the NCDB. The number of cases per year increased from 1783 to 1961, accounting for roughly 0.3% of all reported cancers each year. The proportion of elderly patients increased from 75 to 80%, but distribution by sex remained constant (20% female). The proportion of patients undergoing treatment increased from 34 to 54%. One-year survival increased from 37 to 47% and 3-year survival from 9 to 15% (p < 0.001). Factors associated with improved survival included younger age, female sex, epithelioid histology, treatment in an academic center, health insurance, higher income, and multimodality therapy.
The annual incidence of mesothelioma has not declined this century and remains stable. Reporting of histologic and clinical staging has improved. National trends suggest that survival is slowly increasing despite an aging cohort. Multimodal therapy and treatment at academic centers are modifiable risk factors associated with improved survival.
National Cancer Database
Not otherwise specified
The Mary Elizabeth Holdsworth Fund and Cleveland Clinic Heart and Vascular Institute. Andrew Tang is a National Heart, Lung, and Blood Institute Clinical Research Scholar of the Cardiothoracic Surgical Trials Network (National Institutes of Health Grant U01 HL088955).
- 3.Wagner JC, Sleggs CA, Marchand P (1960) Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J Ind Med 17:260–271Google Scholar
- 13.National cancer database—PUF data dictionary items. https://ncdbpuf.facs.org/node/259. Updated 2017. Accessed 6/15, 2017
- 15.Edge S, Byrd DR, Compton CC, et al. (eds) (2010) AJCC cancer staging manual, 7th edn. Springer, New YorkGoogle Scholar
- 17.Renner RUS (2007) EPA to revisit asbestos toxicity. Environ Sci Technol 41(6):1808–1809Google Scholar
- 19.National Institute for Occupational Safety and Health (NIOSH). Work-Related Lung Disease Surveillance Report. September 2008.Google Scholar
- 20.OSHA, OSHA Fact Sheet. Asbestos. January 2014.Google Scholar
- 35.Tsao AS, Lindwasser OW, Adjei AA, et al. Current and future management of malignant mesothelioma: a consensus report from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation. J Thorac Oncol 13(11):1655–1667.Google Scholar
- 37.National Comprehensive Cancer Network. Malignant Pleural Mesothelioma (Version 2.2018). https://www.nccn.org/professionals/physician_gls/pdf/mpm.pdf.